Research Square · Oct 23, 2026
CT Colonography as a Triage Examination After a Positive Fecal Immunochemical Test: A Retrospective Cohort Study in a Chilean Screening Program
By Subiabre FN, Elgueta RA, Salinas IH et al.
Purpose: To evaluate computed tomography colonography (CTC) as a triage examination for colonoscopy within a fecal immunochemical test (FIT)-based colorectal cancer screening program in a resource-limited region of Chile. Methods: This retrospective cohort study included asymptomatic FIT-positive individuals aged 45–75 years who underwent CTC between January 2019 and November 2022. Patients with CT Colonography Reporting and Data System (C-RADS) C2–C4 findings were referred for optical colonoscopy. The primary outcome was the per-patient positive predictive value (PPV) of CTC for polyps measuring ≥ 6 mm among patients with an evaluable colonoscopy. Results: The cohort comprised 675 patients (mean age 64.0 years, SD 9.2; 443 women, 65.6%). Overall, 473 patients (70.1%) were classified as C1 and were not referred for immediate colonoscopy, 62 (9.2%) had C3–C4 findings and 71 (10.5%) had unresolved C0 examinations. Of 131 patients referred for colonoscopy, 115 (87.8%) underwent the procedure and 108 had an evaluable examination. Colonoscopy confirmed at least one polyp measuring ≥ 6 mm in 93 patients, yielding a PPV of 86.1% (95% CI 78.3–91.4). Advanced colorectal neoplasia was confirmed in 48 patients (PPV 44.4%, 95% CI 35.4–53.8). The detection rates was 42/675 (6.2%) for advanced adenoma and 6/675 (0.9%) for colorectal cancer. Conclusion: Among FIT-positive patients with CTC findings warranting colonoscopy, clinically relevant colorectal lesions were frequently confirmed. CTC may help prioritize colonoscopy in settings with limited endoscopic capacity. Further evaluation of the complete screening pathway is warranted.